Jiang Shuling
Transaction: 05/20/2022
OPTION
Change
0
Price
Not reported
Filing
07/12/2022
Type
OPTION
ABVC BioPharma, Inc.
ABVC • Biotechnology
$0.96
▼ -0.04 (-3.99%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$25.02M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.31Weak liquidity · 0.41Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 20, 2026, 12:19 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.96
Change-3.99%
Shares Out26.06M
Market Cap$25.02M
Enterprise Value$27.55M
52W Range0.82 - 3.40
Beta0.54
P/E-3.46
P/S-31.43
P/B2.43
P/FCF-9.30
EV/Sales-34.61
Price$0.96
Change-3.99%
Shares Out26.06M
Market Cap$25.02M
Enterprise Value$27.55M
52W Range0.82 - 3.40
Beta0.54
P/E-3.46
P/S-31.43
P/B2.43
P/FCF-9.30
EV/Sales-34.61
EV/EBITDA-3.51
EV/FCF-10.24
Earnings Yield-28.93%
FCF Yield-10.76%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.31
Current Ratio0.41
Quick Ratio0.41
Revenue 5Y-100.00%
Volume116.32K
Avg Volume125.97K
EPS Surprise0.15
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
38/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
66/100
Why this score▼
Manageable debt level · 0.31Weak liquidity · 0.41Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
50/100
Neutral
Bullish
0
Hold
1
Bearish
0
Insider Transactions
Recent executive and insider activity
An Chihliang
Transaction: 08/02/2021
SELL
Change
0
Price
Not reported
Filing
03/31/2022
Type
SELL
Odaira Yoshinobu
Transaction: 08/02/2021
SELL
Change
0
Price
Not reported
Filing
12/10/2021
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Jiang Shuling | OPTION | 0 | Not reported | 05/20/2022 | 07/12/2022 |
| An Chihliang | SELL | 0 | Not reported | 08/02/2021 | 03/31/2022 |
| Odaira Yoshinobu | SELL | 0 | Not reported | 08/02/2021 | 12/10/2021 |
| Sakamoto Norimi | OTHER | 0 | Not reported | 08/02/2021 | 12/10/2021 |
| Tseng Shih-Chen | OTHER | 0 | Not reported | 11/08/2021 | 11/15/2021 |
| Jiang Chang-Jen | OPTION | 0 | Not reported | 08/02/2021 | 11/15/2021 |
| Jiang Eugene | OPTION | 0 | Not reported | 08/02/2021 | 11/15/2021 |
| Miao Shin-Yu | OPTION | 0 | Not reported | 08/02/2021 | 11/15/2021 |
| Jiang Tsung Shann | OPTION | 0 | Not reported | 08/02/2021 | 11/15/2021 |
| Doong Howard | SELL | 0 | Not reported | 08/02/2021 | 11/05/2021 |
| Chou Yen-Hsin | SELL | 0 | Not reported | 08/02/2021 | 11/05/2021 |
| King Chi-Hsin Richard | SELL | 0 | Not reported | 08/02/2021 | 11/05/2021 |
| Jiang Tsang Ming | SELL | 0 | Not reported | 08/02/2021 | 10/26/2021 |
| Lazar Shulamit | SELL | 0 | Not reported | 09/08/2015 | 09/08/2015 |
| Stolz Kevin Patrick | BUY | +6,250 | Not reported | 01/27/2012 | 01/27/2012 |
| Krotine Frank Thomas | BUY | +300,000 | $0.20 | 05/25/2011 | 05/25/2011 |
| Ramsey Sally Judith | BUY | +2,100,000 | $0.20 | 05/11/2011 | 05/11/2011 |
| Crockett Robert G | BUY | +1,800,000 | $0.20 | 05/11/2011 | 05/11/2011 |
| IANNOTTI DANIEL V | BUY | +300,000 | $0.20 | 05/11/2011 | 05/11/2011 |
| Stolz Kevin Patrick | BUY | +50,000 | $0.20 | 05/11/2011 | 05/11/2011 |